Skip to main content

Table 2 Comparison of resistance rates for E. coli between the National Surveillance program DANMAP and our study

From: Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark

  DANMAP 2014 Our studya p-value
Ampicillin 39% 34% 0.19
Sulfamethoxazole 32% 28% 0.2
Trimethoprim N/A 20% N/A
Pivmecillinam 5% 4% 0.74
Ciprofloxacin 9% 8% 0.5
Nitrofurantoin N/A 0 N/A
3rd gen. Cephalosporins + clavulanateb 4% 4% 0.96
  1. N/A no data from the National Surveillance program DANMAP 2014
  2. aUncomplicated and complicated cases
  3. bESBL- resistant E. coli